Neumora Therapeutics | IPO Presentation Deck | 32 slides · page 13 of 32
Includes a timeline diagram for the randomized, double-blind treatment phase and a summary table of inclusion criteria and endpoints.
Pitch deck · appendix_methodology · present_framework · dense density
Slide locked Sign in to view
Slide schematic 5/5
diagram 1/1 disclaimer 1/1 list 1/1 table 1/1 title 1/1
Components 5
timeline disclaimer bullet data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1